Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lourdes Florensa

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Haematologica|February 12, 2002
Acute erythroid neoplastic proliferations. A biological study based on 62 patientsAlicia Domingo-Claros, Itziar Larriba, Maruja Rozman, et al.
Genes, Chromosomes & Cancer|April 22, 2004
Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocationMaría Rozman, Mireia Camós, Dolors Colomer, et al.
Haematologica|September 13, 2005
Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromesFrancesc Solé, Elisa Luño, Carmen Sanzo, et al.
Genes|October 27, 2022
Identification of Two Novel <i>EPOR</i> Gene Variants in Primary Familial Polycythemia: Case Report and Literature ReviewLaura Lo Riso, Gardenia Vargas-Parra, Gemma Navarro, et al.
Blood Advances|June 16, 2022
Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuumXavier Calvo, David Roman-Bravo, Nieves Garcia-Gisbert, et al.
Leukemia & Lymphoma|September 22, 2012
Genomic arrays in chronic lymphocytic leukemia routine clinical practice: are we ready to substitute conventional cytogenetics and fluorescence in situ hybridization techniques?Anna Puiggros, Eulàlia Puigdecanet, Marta Salido, et al.
Leukemia Research|November 21, 2007
New chromosomal alterations in a series of 23 splenic marginal zone lymphoma patients revealed by Spectral Karyotyping (SKY)Cristina Baró, Marta Salido, Blanca Espinet, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 27, 2016
Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromesXavier Calvo, Leonor Arenillas, Elisa Luño, et al.
Blood Advances|October 27, 2020
Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic featuresXavier Calvo, Nieves Garcia-Gisbert, Ivonne Parraga, et al.
American Journal of Hematology|April 4, 2017
Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS-R)Xavier Calvo, Leonor Arenillas, Elisa Luño, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Haematologica|February 12, 2002
Acute erythroid neoplastic proliferations. A biological study based on 62 patientsAlicia Domingo-Claros, Itziar Larriba, Maruja Rozman, et al.
Genes, Chromosomes & Cancer|April 22, 2004
Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocationMaría Rozman, Mireia Camós, Dolors Colomer, et al.
Haematologica|September 13, 2005
Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromesFrancesc Solé, Elisa Luño, Carmen Sanzo, et al.
Genes|October 27, 2022
Identification of Two Novel <i>EPOR</i> Gene Variants in Primary Familial Polycythemia: Case Report and Literature ReviewLaura Lo Riso, Gardenia Vargas-Parra, Gemma Navarro, et al.
Blood Advances|June 16, 2022
Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuumXavier Calvo, David Roman-Bravo, Nieves Garcia-Gisbert, et al.
Leukemia & Lymphoma|September 22, 2012
Genomic arrays in chronic lymphocytic leukemia routine clinical practice: are we ready to substitute conventional cytogenetics and fluorescence in situ hybridization techniques?Anna Puiggros, Eulàlia Puigdecanet, Marta Salido, et al.
Leukemia Research|November 21, 2007
New chromosomal alterations in a series of 23 splenic marginal zone lymphoma patients revealed by Spectral Karyotyping (SKY)Cristina Baró, Marta Salido, Blanca Espinet, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 27, 2016
Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromesXavier Calvo, Leonor Arenillas, Elisa Luño, et al.
Blood Advances|October 27, 2020
Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic featuresXavier Calvo, Nieves Garcia-Gisbert, Ivonne Parraga, et al.
American Journal of Hematology|April 4, 2017
Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS-R)Xavier Calvo, Leonor Arenillas, Elisa Luño, et al.
Pageof 6